Dexamethasone in Hospitalized Patients with Covid-19

Cited by (1,035)

Items 601–700 of 1,035

1. The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
   Ahmed M. Alluwaimi, Ibrahim H. Alshubaith, Ahmed M. Al-Ali, Salah Abohelaika · 2020 · Frontiers in Veterinary Science
2. Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future
   Brian Godman, Mainul Haque, Salequl Islam, Samiul Iqbal, Umme Laila Urmi, Zubair Mahmood Kamal, Shahriar Nasim Shuvo, Aminur Rahman, Mustafa Kamal, Monami Haque et al. · 2020 · Frontiers in Public Health
3. Hematological Abnormalities in COVID-19: A Narrative Review
   Asma Rahman, Roshan Niloofa, Umesh Jayarajah, Sanjay De Mel, Visula Abeysuriya, Suranjith Luke Seneviratne · 2021 · American Journal of Tropical Medicine and Hygiene
4. Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2
   Shima Shahbaz, Lai Xu, Mohammed S. Osman, Wendy Sligl, Justin A. Shields, Michael Joyce, D. Lorne Tyrrell, Olaide Oyegbami, Shokrollah Elahi · 2021 · Stem Cell Reports
5. Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic
   Shiva Ambardar, Stephanie L. Hightower, Nikhil Huprikar, Kevin K. Chung, ANJU L SINGHAL, Jacob F. Collen · 2021 · Journal of Clinical Medicine
6. Impact of COVID-19 on the Endocrine System: A Mini-review
   Sophie A. Clarke, Ali Abbara, Waljit Singh Dhillo · 2021 · Endocrinology
7. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
   Ivayla Roberts, Marina Wright Muelas, Joseph M. Taylor, Andrew Davison, Yun Xu A, Justine M. Grixti, Nigel Gotts, Anatolii Sorokin, Royston Goodacre, Douglas Bruce Kell · 2021 · Metabolomics
8. Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis
   Maria Candida Cesta, Mara Zippoli, Carolina Marsiglia, Elizabeth Marie Gavioli, Giada Cremonesi, Akram Khan, Flavio Mantelli, Marcello Allegretti, ROBERT A. BALK · 2022 · European Journal of Immunology
9. Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study
   Rodriguez-Garcia, Jose Luis, Sanchez-Nievas, Gines, Arevalo-Serrano, Juan, Garcia-Gomez, Cristina, Jimenez-Vizuete, Jose Maria, Martinez-Alfaro, Elisa · 2021 · Rheumatology
10. Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak
    Sabaka, P., Koščálová, A., Straka, I., Hodosy, J., Lipták, R., Kmotorková, B., Kachlíková, M., Kušnírová, A. · 2021 · BMC Infectious Diseases
11. COVID-19 and Dexamethasone
    William M. Stauffer, Jonathan D. Alpern, Patricia Frye Walker · 2020 · JAMA
12. The looming storm: Blood and cytokines in COVID-19
    Kaur, Supreet, Bansal, Rashika, Kollimuttathuillam, Sudarsan, Gowda, Anusha Manje, Singh, Balraj, Mehta, Dhruv, Maroules, Michael · 2021 · Blood Reviews
13. Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties
    Michael A. Matthay, Bruce Thompson · 2020 · The Lancet Respiratory Medicine
14. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
    Julio A. Vallejos, Rodrigo Zoni, María del Carmen Bangher, Silvina Villamandos, Angelina Bobadilla, Fabian Plano, Claudia Campias, Evangelina Chaparro Campias, María Fernanda Medina, Fernando Achinelli et al. · 2021 · BMC Infectious Diseases
15. Corticosteroids for COVID-19: the search for an optimum duration of therapy
    Gyanshankar Mishra, Jasmin Mulani · 2020 · The Lancet Respiratory Medicine
16. Tackling the cytokine storm in COVID-19, challenges and hopes
    Shifaa M. Abdin, Sara M. Elgendy, Shatha K. Alyammahi, Dima W. Alhamad, Hany A. Omar · 2020 · Life Sciences
17. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
    Annemarie Beth Docherty, Rachel H. Mulholland, Nazir Lone, Christopher Paul Cheyne, Daniela De Angelis, Karla Diaz‐Ordaz, Cara Donegan, Thomas M Drake, Jake W Dunning, Sebastian Funk et al. · 2021 · The Lancet Respiratory Medicine
18. Long-Term Effects of COVID-19
    Shreeya R. Joshee, Nikhil Vatti, Christopher Chia-Chi Chang · 2022 · Mayo Clinic Proceedings
19. Future directions for the discovery of natural product-derived immunomodulating drugs: an IUPHAR positional review
    Cherry L. Wainwright, Mauro Martins Teixeira, David L. Adelson, Fernão Castro Braga, Eric J. Buenz, Priscilla Rodrigues Valadares Campana, Bruno David, Keith B. Glaser, Yuka Harata‐Lee, Melanie‐Jayne R. Howes et al. · 2022 · Pharmacological Research
20. Pathogenicity and virulence of Aspergillus fumigatus
    Kayleigh Earle, Clara Valero, Daniel P. Conn, George Vere, Peter C. Cook, Michael Bromley, Paul Bowyer, Sara Gago · 2023 · Virulence
21. Monocyte activation in systemic Covid-19 infection: Assay and rationale
    Fernando O. Martínez, Theo Combes, Federica Orsenigo, Siamon Gordon · 2020 · EBioMedicine
22. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
    Fabrizio Cantini, Delia Goletti, Linda Petrone, Saeid Najafi Fard, Laura Niccoli, Rosario Foti · 2020 · Drugs
23. Potential Interaction Between SARS-CoV-2 and Thyroid: A Review
    Wenjie Chen, Yuang Tian, Zhihui Li, Jingqiang Zhu, Tao Wei, Jianyong Lei · 2021 · Endocrinology
24. Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19
    Mayara Bearse, Yin Pun Hung, Aram J. Krauson, Liana Bonanno, Bariş Boyraz, Cynthia K. Harris, T. Leif Helland, Caroline F. Hilburn, Bailey M. Hutchison, Soma Jobbagy et al. · 2021 · Modern Pathology
25. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects
    Giuseppe Lisco, Anna De Tullio, Emilio Jirillo, Vito Angelo Giagulli, Giovanni De Pergola, Edoardo Guastamacchia, Vincenzo Triggiani · 2021 · Journal of Endocrinological Investigation
26. Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
    Federico Angriman, Bruno Leonel Ferreyro, Lisa D. Burry, Eddy Fan, Niall D. Ferguson, Shahid Husain, Shaf H Keshavjee, Enrico Lupia, Laveena Munshi, Samuele Renzi et al. · 2021 · The Lancet Respiratory Medicine
27. Current Strategies of Antiviral Drug Discovery for COVID-19
    Miao Mei, Xu Tan · 2021 · Frontiers in Molecular Biosciences
28. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
    Jason D. Goldman, Philip Cameron Robinson, Thomas S. Uldrick, Per T Ljungman · 2021 · Journal for ImmunoTherapy of Cancer
29. Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children
    Kanwal M. Farooqi, Angela Chan, Rachel J. Weller, Junhui Mi, Pengfei Jiang, Elizabeth Abrahams, Anne M. Ferris, Usha Krishnan, Nikhil Pasumarti, Sanghee Suh et al. · 2021 · PEDIATRICS
30. Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19
    Xavier Solanich, Gardenia Vargas‐Parra, Caspar I. van der Made, Annet Simons, Janneke H. M. Schuurs-Hoeijmakers, Arnau Antolí, Jesús Del Valle, Gemma Rocamora-Blanch, Fernando Setién, Manel Esteller et al. · 2021 · Frontiers in Immunology
31. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
    John F. Fullard, Hao-Chih Lee, Georgios Voloudakis, Shengbao Suo, Behnam Javidfar, Zhiping Shao, Cyril Jayakumar Peter, Wen Zhang, Shan Jiang, André Corvelo et al. · 2021 · Genome Medicine
32. Acute Respiratory Distress Syndrome
    George W. Williams, Nathaniel K. Berg, Alexander Reskallah, Xiaoyi Yuan, Holger K. Eltzschig · 2020 · Anesthesiology
33. Therapeutics for COVID-19
    Sima S. Toussi, Jennifer Hammond, Brian S. Gerstenberger, Annaliesa S. Anderson · 2023 · Nature Microbiology
34. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
    Hsin‐I Shih, Chi-Jung Wu, Yi‐Fang Tu, Chia‐Yu Chi · 2020 · Biomedical Journal
35. Management of Heart Failure Patients with COVID-19: A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology
    Yuhui Zhang, Andrew J.S. Coats, Zhe Zheng, Marianna Adamo, Giuseppe Ambrosio, Stefan D. Anker, Javed Butler, Dingli Xu, Jingyuan Mao, Muhammad Shahzeb Khan et al. · 2020 · European Journal of Heart Failure
36. SARS-CoV-2 infection in patients with autoimmune hepatitis
    Thomas Marjot, Gustav Buescher, Marcial Sebode, Eleanor J. Barnes, Alfred Sidney Barritt, Matthew James Armstrong, Luke Baldelli, James M Kennedy, Carolyn Mercer, Ann‐Kathrin Ozga et al. · 2021 · Journal of Hepatology
37. A practical guide for the management of steroid induced hyperglycaemia in the hospital
    Aberer, Felix, Hochfellner, Daniel A., Sourij, Harald, Mader, Julia K. · 2021 · Journal of Clinical Medicine
38. Coronavirus Disease 2019–Associated Invasive Fungal Infection
    John W. Baddley, George R. Thompson, Sharon C.‐A. Chen, Philip Lewis White, Melissa D. Johnson, M. Hong Nguyen, Ilan Steven Schwartz, Andrej Spec, Luis Ostrosky‐Zeichner, Brendan R. Jackson et al. · 2021 · Open Forum Infectious Diseases
39. Sexual dimorphism in COVID-19: potential clinical and public health implications
    Nicole Bechmann, Andreas Barthel, Andreas Schedl, Stephan Herzig, Zsuzsanna Varga, Cathérine Gebhard, Manuel Mayr, Constanze Hantel, Felix Beuschlein, Christian Wolfrum et al. · 2022 · Publikationen an der Universität Bielefeld (Universität Bielefeld)
40. Recent developments in the immunopathology of COVID ‐19
    Huanping Zhang, Yuanli Sun, Yanfen Wang, Duygu Yazıcı, Dilek Azkur, İsmail Öğülür, Ahmet Kürşat Azkur, Zhaowei Yang, Xiao‐xue Chen, Ai‐Zhi Zhang et al. · 2022 · Allergy
41. Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates
    Qian‐Fang Meng, Wanbo Tai, Mingyao Tian, Xinyu Zhuang, Yuanwei Pan, Jialin Lai, Yangtao Xu, Zhiqiang Xu, Min Li, Guangyu Zhao et al. · 2023 · Science Advances
42. Network medicine framework for identifying drug-repurposing opportunities for COVID-19
    Morselli Gysi, Deisy, do Valle, Ítalo, Zitnik, Marinka, Ameli, Asher, Gan, Xiao, Varol, Onur, Ghiassian, Susan Dina, Patten, J. J., Davey, Robert A., Loscalzo, Joseph et al. · 2021 · Proceedings of the National Academy of Sciences
43. Haematological manifestations of COVID‐19: From cytopenia to coagulopathy
    Charles Agbuduwe, Supratik Basu · 2020 · European Journal Of Haematology
44. Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study
    Juan Francisco Alcala-Diaz, Laura Limia Pérez, Ricardo Gómez‐Huelgas, María Dolores Martín Escalante, Begoña Cortés Rodríguez, José Luis Zambrana-García, Marta Entrenas Castillo, Ana Isabel Pérez-Caballero, Maria Dolores Lopez-Carmona, Javier García‐Alegría et al. · 2021 · Nutrients
45. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study
    Nuttha Lumlertgul, Leah Pirondini, Enya Cooney, Waisun Kok, John Gregson, Luigi Camporota, Katie Lane, Richard M. Leach, Marlies Ostermann · 2021 · Annals of Intensive Care
46. COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
    Filippo Fagni, David Simón, Koray Taşçılar, V. Schönau, Michael Sticherling, Markus Friedrich Neurath, Georg Andreas Schett · 2021 · The Lancet Rheumatology
47. Sexual dimorphism in COVID-19: potential clinical and public health implications
    Nicole Bechmann, Andreas Barthel, Andreas Schedl, Stephan Herzig, Zsuzsanna Varga, Cathérine Gebhard, Manuel Mayr, Constanze Hantel, Felix Beuschlein, Christian Wolfrum et al. · 2022 · The Lancet Diabetes & Endocrinology
48. Management of severe acute respiratory distress syndrome: a primer
    John C. Grotberg, Daniel Reynolds, Bryan D. Kraft · 2023 · Critical Care
49. SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’
    Pierre D. Kory, Jeffrey P. Kanne · 2020 · BMJ Open Respiratory Research
50. Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study
    Fernanda Lima‐Setta, Maria Clara de Magalhães‐Barbosa, Gustavo Rodrigues-Santos, Elaine Augusta das Neves Figueiredo, Melissa de Lorena Jacques, Raquel de Seixas Zeitel, Roberto Sapolnik, Cibelle Teixeira da Siva Borges, Vanessa Soares Lanziotti, Roberta Esteves Vieira de Castro et al. · 2020 · Jornal de Pediatria
51. In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
    Anisha S Jain, Sushma Pradeep, Chandan Dharmashekar, Mallikarjun S Beelagi, Shashanka K. Prasad, Chandan Shivamallu, Ashwini Prasad, Asad Syed, Najat Marraiki, Kollur Shiva Prasad · 2020 · Saudi Journal of Biological Sciences
52. DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France
    Maria Pia Sormani, Marco Salvetti, Pierre M. Labauge, Irene Schiavetti, Hélène Zéphir, Luca Carmisciano, Caroline Bensa, Nicola De Rossi, Jean Pelletier, Cinzia Cordioli et al. · 2021 · Annals of Clinical and Translational Neurology
53. TheStaphylococcus aureusNetwork Adaptive Platform Trial Protocol: New Tools for an Old Foe
    Steven Y. C. Tong, Jocelyn M Mora, Asha C Bowen, Matthew Pellan Cheng, Nick Daneman, Anna L. Goodman, George Heriot, Todd Campbell Lee, Roger J. Lewis, David Chien Lye et al. · 2022 · Clinical Infectious Diseases
54. SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses
    Shufen Li, Yulan Zhang, Zhenqiong Guan, Meidi Ye, Huiling Li, Miaomiao You, Zhenxing Zhou, Chongtao Zhang, Fan Zhang, Ben Lü et al. · 2023 · Cell Research
55. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals
    Ronald Andrew Seaton, Cheryl Gibbons, Lesley Cooper, William Malcolm, Rachel McKinney, Stephanie Dundas, David M Griffith, Danielle Jeffreys, Kayleigh Hamilton, Brian Choo‐Kang et al. · 2020 · Journal of Infection
56. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis
    Vincenzo Cardinale, Gabriele Capurso, Gianluca Ianiro, Antonio Gasbarrini, Paolo Giorgio Arcidiacono, Domenico Alvaro · 2020 · Digestive and Liver Disease
57. Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles
    Akshamal Mihiranga Gamage, Kai Sen Tan, Wharton O. Y. Chan, Jing Liu, Chee Wah Tan, Yew Kwang Ong, Mark Kim Thye Thong, Anand Kumar Andiappan, Danielle E. Anderson, De Yun Wang et al. · 2020 · PLoS Pathogens
58. Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission
    Nicolette Wierdsma, Hinke M. Kruizenga, Lotte AML. Konings, Daphne Krebbers, Jolein RMC. Jorissen, Marie-Helene I. Joosten, Loes H. van Aken, Flora M. Tan, Adriaan Anthonie Van Bodegraven, Maarten R. Soeters et al. · 2021 · Clinical Nutrition ESPEN
59. Infectious disease-associated encephalopathies
    Maria Carolina Barbosa‐Silva, Maiara N. Lima, Denise Battaglini, Chiara Robba, Paolo P. Pelosi, Patrícia R. M. Rocco, Tatiana Maron‐Gutierrez · 2021 · Critical Care
60. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
    Ali Attiq, Lui Jin Yao, Sheryar Afzal, Mansoor Ali Khan · 2021 · International Immunopharmacology
61. Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
    Levente Zsichla, Viktor Müller · 2023 · Viruses
62. Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
    Igor Andrade Santos, Victória Riquena Grosche, Fernando R.G. Bergamini, Robinson Sabino Silva, Ana Carolina Gomes Jardim · 2020 · Frontiers in Microbiology
63. Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes
    Mina Thabet Kelleni · 2020 · Biomedicine & Pharmacotherapy
64. Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial
    Joseph Michael Miller, Charles A. Bruen, Michael J. Schnaus, Jeffrey Zhang, Sádia Ali, April Lind, Zachary R. Stoecker, Kenneth A. Stauderman, Sudarshan Hebbar · 2020 · Critical Care
65. Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study
    Javier Martínez‐Sanz, Alfonso Muriel, Raquel Ron, Sabina Herrera, José Antonio Pérez-Molina, Santiago Moreno, Sergio Serrano Villar · 2020 · Clinical Microbiology and Infection
66. Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis: A systematic review and meta‐analysis
    H. Mitaka, T. Kuno, H. Takagi, P. Patrawalla · 2021 · Mycoses (Berlin)
67. Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
    L. Dupont, L. Snell, C. Graham, J. Seow, B. Merrick, T. Lechmere, T. Maguire, Sadie R. Hallett, S. Pickering, T. Charalampous et al. · 2021 · Nature Microbiology
68. Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management
    Eleanor J. Molloy, Natasha A. Nakra, Chris Gale, Victoria R. Dimitriades, Satyan Lakshminrusimha · 2022 · Pediatric Research
69. A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae
    Peter Myles George, Anna K. Reed, Sujal R. Desai, Anand Devaraj, Tasnim Shahridan Faiez, Sarah Laverty, Amama Kanwal, Camille Esneau, Michael K. P. Liu, Faisal Kamal et al. · 2022 · Science Translational Medicine
70. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
    Hector Fabio Bonilla, Michael J. Peluso, Kathleen E. Rodgers, Judith A. Aberg, Thomas F. Patterson, Robert F. Tamburro, Lawrence Baizer, Jason D. Goldman, Nadine Rouphael, Amelia N. Deitchman et al. · 2023 · Frontiers in Immunology
71. A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging?
    Bektas, Arsun, Schurman, Shepherd H., Franceschi, Claudio, Ferrucci, Luigi · 2020 · Immunity & Ageing
72. The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge
    Maja Buszko, Jung‐Hyun Park, Daniela I. Verthelyi, Ranjan Sen, Howard A. Young, Amy S. Rosenberg · 2020 · Nature Immunology
73. Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients
    Reed B. Hogan, Reed B. Hogan, Tim Cannon, Maria Rappai, John Studdard, Doug Paul, Thomas P. Dooley · 2020 · Pulmonary Pharmacology & Therapeutics
74. Is the Frequency of Candidemia Increasing in COVID-19 Patients Receiving Corticosteroids?
    Cezar Vinícius Würdig Riche, Renato Cassol, Alessandro Comarú Pasqualotto · 2020 · Journal of Fungi
75. Associations between COVID-19-Related Digital Health Literacy and Online Information-Seeking Behavior among Portuguese University Students.
    Rosário, Rafaela, Martins, Maria R. O., Augusto, Cláudia, Silva, Maria José, Martins, Silvana, Duarte, Ana, Fronteira, Inês, Ramos, Neida, Okan, Orkan, Dadaczynski, Kevin · 2020 · International Journal of Environmental Research and Public Health
76. COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
    Daniele Focosi, Massimo Franchini, Liise‐anne Pirofski, Thierry Pierre Robert Burnouf, Nigel Paneth, Michael J. Joyner, Arturo Casadevall · 2022 · Clinical Microbiology Reviews
77. Specialized pro-resolving mediators as modulators of immune responses
    Walker A. Julliard, Y.P.A. Myo, Apostolos Perelas, Peter Jackson, Thomas H. Thatcher, Patricia J. Sime · 2022 · Seminars in Immunology
78. A pairwise cytokine code explains the organism-wide response to sepsis
    Michihiro Takahama, Ashwini Patil, Katherine Johnson, Denis Cipurko, Yoshimi Miki, Yoshitaka Taketomi, Peter S. Carbonetto, Madison Plaster, Gabriella Richey, Surya Pandey et al. · 2024 · Nature Immunology
79. Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
    Janine Alessi, Giovana Berger de Oliveira, Beatriz D'Agord Schaan, Gabriela Heiden Teló · 2020 · Diabetology & Metabolic Syndrome
80. Current and evolving standards of care for patients with ARDS
    Mario Menk, Elisa Estenssoro, Sarina K. Sahetya, Ary Serpa Neto, Pratik Sinha, Arthur S. Slutsky, Charlotte Summers, Takeshi Yoshida, Thomas Bein, Niall D. Ferguson · 2020 · Intensive Care Medicine
81. Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic
    Jeffrey R. Strich, Marcos Javier Ramos-Benítez, Davide Randazzo, Sydney R. Stein, Ashley L. Babyak, Richard T. Davey, Anthony F. Suffredini, Richard W. Childs, Daniel S. Chertow · 2020 · The Journal of Infectious Diseases
82. One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview
    Matheus Negri Boschiero, Camila Vantini Capasso Palamim, Manoela Marques Ortega, Renan Marrichi Mauch, Fernando Augusto Lima Marson · 2021 · Annals of Global Health
83. Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality
    Justin M. Snider, Jeehyun Karen You, Xia Wang, Ashley J. Snider, Brian Hallmark, Manja M. Zec, Michael C. Seeds, Susan Sergeant, Laurel M. Johnstone, Qiuming Wang et al. · 2021 · Journal of Clinical Investigation
84. Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals
    D. Meekins, N. Gaudreault, J. Richt · 2021 · Viruses
85. COVID-19 and Sepsis
    Zeliha Koçak Tufan, Bircan Kayaaslan, Mervyn Mer · 2021 · TURKISH JOURNAL OF MEDICAL SCIENCES
86. Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19
    Calum T. Robb, Marie Goepp, Adriano Giorgio Rossi, Chengcan Yao · 2020 · British Journal of Pharmacology
87. Case Report: Adrenal Pathology Findings in Severe COVID-19: An Autopsy Study
    Monique Freire Santana, Mayla Gabriela Silva Borba, Djane Clarys Baía-da-Silva, Fernando Val, Márcia Almeida Araújo Alexandre, José Diego Brito-Sousa, Gisely Cardoso de Melo, Marcos Vinícius Oliveira Queiroga, Maria Eduarda Leão de Farias, Cecília Cunha Camilo et al. · 2020 · American Journal of Tropical Medicine and Hygiene
88. The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
    Esmé Jansen van Vuren, Stephan F. Steyn, Christiaan Beyers Brink, Marisa Möller, Francois P. Viljoen, Brian Herbert Harvey · 2021 · Biomedicine & Pharmacotherapy
89. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury
    Roberto F. Nicosia, Giovanni Ligresti, Nunzia Caporarello, Shreeram Akilesh, Doménico Ribatti · 2021 · American Journal Of Pathology
90. Chronic obstructive pulmonary disease and COVID-19: interrelationships
    Dave Singh, Alexander G. Mathioudakis, Andrew Higham · 2021 · Current Opinion in Pulmonary Medicine
91. Sex‐related differences in COVID‐19 lethality
    Claudia Renata Rezende Penna, Valentina Mercurio, Carlo Gabriele Tocchetti, Pasquale Pagliaro · 2020 · British Journal of Pharmacology
92. Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children
    Zahra Belhadjer, Johanne Auriau, Mathilde Méot, Mehdi Oualha, Sylvain Renolleau, Lucile Houyel, Damien Bonnet · 2020 · Circulation
93. Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials
    Laura Pasin, Paolo Navalesi, Alberto Zangrillo, Artem N. Kuzovlev, Valery V. Likhvantsev, Ludhmila Abrahão Hajjar, Stefano Fresilli, Marcus Lacerda, Giovanni Landoni · 2020 · Journal of Cardiothoracic and Vascular Anesthesia
94. A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19
    Justine J. Ko, Clay Wu, Neha Mehta, Noah Wald‐Dickler, Wei Yang, Renli Qiao · 2021 · Journal of Intensive Care Medicine
95. Corticosteroids for COVID-19
    Djillali Annane · 2021 · Journal of Intensive Medicine
96. The Epidemiology of Acute Respiratory Distress Syndrome Before and After Coronavirus Disease 2019
    Kathryn W. Hendrickson, Ithan D. Peltan, Samuel Morris Brown · 2021 · Critical Care Clinics
97. Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities
    Steven Chee Loon Lim, Chee Peng Hor, Kim Heng Tay, Anilawati Mat Jelani, Wen Hao Tan, Hong Bee Ker, Ting Soo Chow, Masliza Zaid, Wee Kooi Cheah, Han Hua Lim et al. · 2022 · JAMA Internal Medicine
98. Influenza antivirals and their role in pandemic preparedness
    Jeremy C. Jones, Hui‐Ling Yen, Peter Adams, Kimberly L. Armstrong, Elena A. Govorkova · 2022 · Antiviral Research
99. Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
    Chandan Kumar Sarkar, Milon Mondal, Muhammad Torequl Islam, Miquel Martorell, Anca Oana Docea, Alfred Maroyi, Javad Sharifi‐Rad, Daniela Cornelia Călina · 2020 · Frontiers in Pharmacology
100. Safety of Remdesivir in Patients With Acute Kidney Injury or CKD
     Sayali B. Thakare, Chintan Gandhi, Tulsi Modi, Sreyashi Bose, Satarupa Deb, Nikhil Saxena, Abhinav Katyal, Ankita Patil, Sunil KG Patil, Atim E. Pajai et al. · 2020 · Kidney International Reports